Correction: Ibrutinib as treatment for Bing-Neel syndrome reclassified as glioblastoma: a case report.

IF 0.8 Q3 MEDICINE, GENERAL & INTERNAL

Journal of Medical Case Reports Pub Date : 2025-08-19 DOI:10.1186/s13256-025-05494-7

Charlotte Dahl Gravesen, Iman Chanchiri, Ida Bruun Kristensen, Martin Bang Jensen, Frederik Severin Gråe Harbo, Rikke Hedegaard Dahlrot

引用次数: 0

查看原文本刊更多论文

更正：依鲁替尼治疗Bing-Neel综合征重新分类为胶质母细胞瘤：1例报告。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Medical Case Reports Medicine-Medicine (all)

CiteScore

1.50

自引率

0.00%

发文量

436

期刊介绍： JMCR is an open access, peer-reviewed online journal that will consider any original case report that expands the field of general medical knowledge. Reports should show one of the following: 1. Unreported or unusual side effects or adverse interactions involving medications 2. Unexpected or unusual presentations of a disease 3. New associations or variations in disease processes 4. Presentations, diagnoses and/or management of new and emerging diseases 5. An unexpected association between diseases or symptoms 6. An unexpected event in the course of observing or treating a patient 7. Findings that shed new light on the possible pathogenesis of a disease or an adverse effect